During my first 12 months, I have 4 key priorities that are designed to increase shareholder value: First and foremost is to secure capital. In this effort, I am, of course, working closely with our CFO, Keith Goldan. As we announced this morning, we amended our credit facility to reduce the amount of unrestricted cash that we are required to maintain from $3 million to $1 million. With this amendment, we believe our existing cash and cash equivalents will be sufficient to fund debt service and interest obligations and continue operations until the end of the third quarter. To meet our capital needs beyond this point, we are considering multiple alternatives to ensure that we're properly capitalized to achieve our objectives.

Read the rest of this transcript for free on seekingalpha.com

If you liked this article you might like

Teva (TEVA) Acquires NuPathe (PATH) for $144 Million

NuPathe Picks Teva as Merger Partner

Why NuPathe Inc. (PATH) Is Up Today

Nupathe's Failure to Launch Leads to Modest Takeover

5 Stocks Under $10 Set to Soar